| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.19 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |